MenuCrospovidone – Premium superdisintegrant enhancing solubility and therapeutic performance
Menu
Loading...

Crospovidone – Premium superdisintegrant enhancing solubility and therapeutic performance

1. General Introduction of Crospovidone

Crospovidone is a cross-linked, water-insoluble polymer widely used as a premium superdisintegrant in advanced pharmaceutical formulations. Its unique porous structure enables rapid water uptake and fast tablet disintegration, making it a critical excipient for modern, high-performance dosage forms.

Commercially, crospovidone is available in optimized grades such as PolyKoVidone XL (Type A, ~125 µm) and PolyKoVidone XL-10 (Type B, ~30 µm), each engineered for specific formulation needs from rapid capillary action to enhanced mouthfeel in orally disintegrating tablets (ODT).

crospovidone is not just a functional excipient, it is a key driver for improving drug performance, accelerating onset of action, and enhancing patient compliance.

2. Properties & Mechanism of Crospovidone

Crospovidone is a cross-linked homopolymer of N-vinyl-2-pyrrolidone (PVP), engineered into an insoluble, highly porous three dimensional network.

This cross linked structure eliminates solubility while preserving strong hydrophilicity, enabling rapid water uptake through capillary action without forming a viscous gel layer. As a result, crospovidone maintains continuous liquid penetration pathways within the tablet matrix.

PolyKoVidone® XL (Type A, ~125 µm) and PolyKoVidone® XL-10 (Type B, ~30 µm) are differentiated by particle size distribution, which directly impacts disintegration kinetics:

 

PolyKoVidone® XL

PolyKoVidone® XL-10

Type

A

B

Particle size (µm)

125

30

Applications

Suitable for most immediate-release tablet formulations. The larger particle size enables rapid swelling and strong water uptake, resulting in highly efficient disintegration. Particularly suitable for herbal and traditional medicine formulations.

With a smaller particle size, it is ideal for chewable tablets and orally disintegrating tablets (ODT), providing fast and smooth disintegration with improved mouthfeel.

3. Key advantages of Crospovidone

  • Rapid disintegration at low concentration (1–5%), reducing excipient load while maintaining performance
  • Triple-action mechanism (wicking, swelling, and shape recovery) ensures fast and complete tablet breakup
  • Excellent compressibility, enabling high tablet hardness with low friability—even for poorly compressible APIs
  • Strong wetting capability, promoting rapid liquid penetration into dense tablet matrices
  • Non-ionic nature, eliminating incompatibility risks with ionic APIs (e.g., ranitidine, cetirizine)
  • No gel formation even at high levels (~10%), preserving drug release kinetics
  • pH-independent performance, ensuring consistent disintegration across physiological environments
  • Enhances stability, dissolution, and bioavailability of poorly soluble drugs (BCS II & IV)
  • Flexible processing compatibility: direct compression, wet granulation, and dry granulation

PolyKoVidone® can be used both intra- and extra-granularly, delivering synergistic disintegration efficiency and superior formulation robustness.

4. Applications of Crospovidone

Crospovidone is widely utilized in pharmaceutical formulations due to its exceptional disintegration performance and versatile functionality across multiple dosage forms.

  • Superdisintegrant in immediate release tablets: Crospovidone is primarily used as a superdisintegrant in immediate-release (IR) tablet formulations. Its rapid capillary activity (wicking) and swelling without gel formation enable tablets to break apart quickly upon contact with gastrointestinal fluids, ensuring fast drug release and onset of action.
  • Key Excipient in orally disintegrating tablets (ODTs): In orally disintegrating tablets, Crospovidone plays a critical role in achieving ultra-fast disintegration in the oral cavity without the need for water. Its high porosity and rapid water uptake contribute to improved patient compliance, especially for pediatric, geriatric, and dysphagic populations.
  • Disintegration aid in capsules and granules: Crospovidone is also incorporated into hard capsules and granule formulations to enhance dispersion and disintegration. It ensures uniform release of the active pharmaceutical ingredient (API), improving consistency and reliability of drug delivery.
  • Enhancement of poorly soluble drug performance: For Biopharmaceutics Classification System (BCS) Class II and IV drugs, Crospovidone significantly enhances dissolution rates. By improving wettability and increasing surface area exposure, it facilitates faster drug solubilization, leading to improved bioavailability.
  • Improvement of drug release and therapeutic efficiency: The inclusion of Crospovidone accelerates dissolution kinetics and promotes efficient drug release profiles. This results in enhanced therapeutic efficacy, reduced variability in drug absorption, and potentially lower required dosages.

Overall, Crospovidone is a highly effective multifunctional excipient that not only ensures rapid disintegration but also contributes to improved drug performance and patient outcomes.

5. Sample Products using Crospovidone 

Protonix (Pantoprazole Sodium) | PharmaServe
A white box with blue and orange text
AI-generated content may be incorrect.

 6. Product contact information 

For more information about Crospovidone sourcing, please contact us:

 

RELATED ARTICLES

THƯ VIỆN ẢNH